decisionhealth Newsletters, Coder Pink Sheets - 2003 Issue 2 (February)
CODING Q&A_Use V10.46 for PSA recall diagnosis
Subscribe or sign in to view the full article.
Article Overview
This short Find-A-Code coding Q&A addresses diagnosis coding for PSA recall visits after prostate cancer treatment. It is aimed at coders and billing staff who need to distinguish follow-up coding from screening and understand the broad context for prostate cancer-related testing across payer settings. The article also notes the related screening test context and references the organizations and code sets involved, without replacing the need to review the full guidance.
Why This Topic Matters
Correctly classifying a PSA recall visit affects claim accuracy and helps avoid using a screening or active-disease diagnosis when the visit is for post-treatment follow-up. The article is relevant to practices that code prostate cancer surveillance services and want to align diagnosis selection with the documented visit purpose.
What You Will Learn
- How the article frames PSA recall visits after prostate cancer treatment
- How the article distinguishes follow-up from screening in broad coding terms
- Which code sets are referenced for prostate cancer surveillance and screening context
- How payer context can affect the related screening service discussion
Who Should Read This
- Medical coders
- Billing staff
- Claims staff
- Physician office staff
- Revenue cycle professionals
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com